Yanan Zheng

机构：Zhongda Hospital Southeast University, Gannan Medical University, Suzhou Municipal Hospital, Second Affiliated Hospital of Nanjing Medical University, Gilead Sciences (United States), Southeast University · ORCID：0000-0003-3076-0003

发表论文 20 篇 · 总被引 271 次 · h-index 9

代表论文

• Prognostic Significance of Liver Metastasis in Durvalumab-Treated Lung Cancer Patients (2019 · Clinical Lung Cancer · 被引 61)
• Biphasic Regulation of Renal Proximal Bicarbonate Absorption by Luminal AT1A Receptor (2003 · Journal of the American Society of Nephrology · 被引 48)
• Safety of teropavimab and zinlirvimab with lenacapavir once every 6 months for HIV treatment: a phase 1b, randomised, proof-of-concept study (2024 · The Lancet HIV · 被引 47)
• Pharmacokinetic and Pharmacodynamic Modeling of Tezepelumab to Guide Phase 3 Dose Selection for Patients With Severe Asthma (2020 · The Journal of Clinical Pharmacology · 被引 27)
• Model-based clinical pharmacology profiling and exposure-response relationships of the efficacy and biomarker of lebrikizumab in patients with moderate-to-severe asthma (2017 · Pulmonary Pharmacology & Therapeutics · 被引 18)
• Exposure-efficacy and safety analysis of durvalumab in patients with urothelial carcinoma (UC) and other solid tumors. (2017 · Journal of Clinical Oncology · 被引 16)